๐ฌIn plain words
What the trial is, and whether it could suit you
A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.
Sign in to get the eligibility rules as simple questions to take to your doctor.
๐ Eligibility rules (as published)
Inclusion Criteria:
* Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
* Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
* Between the ages of 4 and 17 years of age.
* Documented neurogenic bladder dysfunction
* On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial
Exclusion Criteria:
* Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator.
* Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months.
* Is pregnant. Pregnancy will be assessed via verbal report.
* Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation.
* Implanted or attached electronic device in any location of the body (e.g. pacemakers, baclofen pumps, or implanted insulin pumps)
* Symptomatic urinary tract infection, urinary tract infection for which they are currently receiving treatment, scheduled urological surgery, or inability to perform or receive catheterization.
๐
What it tests
- Transcutaneous stimulator
University of Pittsburgh
Pittsburgh, United States
๐ค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ always decide together with your own doctor.